|
Well its not simply clinical trials they work on. They do a kind of calculation based on extended quality of life for a cost benefit case and if that comes out too expensive they wont allow it to be used. This is the problem with NICE in the UK they are cost driven as well which is why the UK have so much trouble getting these new drugs.
|